Patricia Hernández

688 total citations
22 papers, 498 citations indexed

About

Patricia Hernández is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Patricia Hernández has authored 22 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Rheumatology. Recurrent topics in Patricia Hernández's work include Systemic Lupus Erythematosus Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Neonatal Respiratory Health Research (2 papers). Patricia Hernández is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Neonatal Respiratory Health Research (2 papers). Patricia Hernández collaborates with scholars based in United States, Cuba and Spain. Patricia Hernández's co-authors include T. Murphy Goodwin, Manuel Durand, Richard H. Paul, Pedro C. Rodríguez, John W. Goethe, Steven E. Wolf, Rose Maljanian, Ernesto Moreno, Alfonso Dueñas‐González and Jorge Meléndez-Zajgla and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Patricia Hernández

21 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Hernández United States 12 172 156 93 69 60 22 498
Sônia K. Nishida Brazil 17 72 0.4× 85 0.5× 75 0.8× 17 0.2× 44 0.7× 42 669
Anders Erik Astrup Dahm Norway 18 59 0.3× 62 0.4× 77 0.8× 21 0.3× 28 0.5× 56 1.1k
Eva Mildenberger Germany 17 409 2.4× 292 1.9× 42 0.5× 84 1.2× 88 1.5× 94 915
Metin İngeç Türkiye 17 49 0.3× 183 1.2× 37 0.4× 31 0.4× 66 1.1× 42 678
Jacques Lombet Belgium 13 265 1.5× 174 1.1× 18 0.2× 89 1.3× 34 0.6× 28 598
Kenneth Chan United Kingdom 19 119 0.7× 212 1.4× 90 1.0× 27 0.4× 29 0.5× 74 1.1k
Jens Drube Germany 16 73 0.4× 175 1.1× 35 0.4× 13 0.2× 33 0.6× 33 662
Hayato Go Japan 11 189 1.1× 111 0.7× 18 0.2× 31 0.4× 17 0.3× 65 442
Noriyoshi Watanabe Japan 14 47 0.3× 189 1.2× 44 0.5× 38 0.6× 23 0.4× 28 529
Naci Kemal Kuşçu Türkiye 13 51 0.3× 118 0.8× 63 0.7× 16 0.2× 33 0.6× 34 572

Countries citing papers authored by Patricia Hernández

Since Specialization
Citations

This map shows the geographic impact of Patricia Hernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Hernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Hernández more than expected).

Fields of papers citing papers by Patricia Hernández

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Hernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Hernández. The network helps show where Patricia Hernández may publish in the future.

Co-authorship network of co-authors of Patricia Hernández

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Hernández. A scholar is included among the top collaborators of Patricia Hernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Hernández. Patricia Hernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández, Patricia, et al.. (2023). Temporal Artery Ultrasound for the Diagnosis of Giant Cell Arteritis in the Emergency Department. Cureus. 15(7). e42350–e42350. 2 indexed citations
2.
Hernández, Patricia, et al.. (2021). Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis. Current Atherosclerosis Reports. 23(11). 72–72. 37 indexed citations
3.
Guerra, Carmen E., Sheila Kelly, Colleen Redlinger, Patricia Hernández, & Karen Glanz. (2021). Pancreatic Cancer Clinical Treatment Trials Accrual. American Journal of Clinical Oncology. 44(6). 227–231. 3 indexed citations
4.
Cielo︎, Christopher M., et al.. (2020). Positive Airway Pressure for the Treatment of OSA in Infants. CHEST Journal. 159(2). 810–817. 20 indexed citations
5.
Perales‐Puchalt, Alfredo, Elizabeth K. Duperret, Xue Yang, et al.. (2019). DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity. JCI Insight. 4(8). 36 indexed citations
6.
Hernández, Patricia, et al.. (2016). Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab. Current Drug Targets. 17(6). 666–677. 27 indexed citations
7.
Hernández, Patricia, et al.. (2015). Homocysteine, implications in cardiovascula risk. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 1 indexed citations
8.
Hernández, Patricia, et al.. (2015). Immunological evaluation of rheumatoid arthritis patients treated with itolizumab. mAbs. 8(1). 187–195. 15 indexed citations
9.
10.
López‐Requena, Alejandro, et al.. (2014). Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab. mAbs. 6(3). 782–792. 25 indexed citations
11.
Richardet, Martin Eduardo, et al.. (2014). PSA values as a surrogate of overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC) treated with second-line (2L) chemotherapy (CT).. Journal of Clinical Oncology. 32(15_suppl). e16104–e16104. 1 indexed citations
12.
Rodríguez, Pedro C., Gil Reyes, M.V. Hernández, et al.. (2012). A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis. PubMed. 2. 204–211. 33 indexed citations
13.
Hernández, Patricia, et al.. (2008). A Multicentric, Cross-Sectional Glaucoma Study in Buenos Aires, Argentina. Preliminary Report: Relative Frequency, Age, Bilaterality and Gender. Investigative Ophthalmology & Visual Science. 49(13). 3608–3608. 1 indexed citations
14.
Hernández, Patricia, René Delgado, & Henning Walczak. (2006). Mangifera indica L. extract protects T cells from activation-induced cell death. International Immunopharmacology. 6(9). 1496–1505. 11 indexed citations
15.
Hernández, Patricia, et al.. (2005). [Asphyxiation by suffocation and strangulation in children younger than 15 years of age].. PubMed. 140(5). 503–6. 7 indexed citations
16.
Hernández, Patricia, et al.. (2001). Gemcitabine activity in cervical cancer cell lines. Cancer Chemotherapy and Pharmacology. 48(6). 488–492. 41 indexed citations
17.
Goethe, John W., et al.. (2001). The impact of depressive symptoms on the functional status of inner-city patients with asthma. Annals of Allergy Asthma & Immunology. 87(3). 205–210. 40 indexed citations
18.
Hernández, Patricia, et al.. (2000). A Mouse Fibroblast Cell Model to Study Human Papillomavirus-Associated Tumorigenesis. Biochemical and Biophysical Research Communications. 270(1). 119–124. 9 indexed citations
19.
Knobel, Hernando, et al.. (1997). [Acceptance of, compliance with and tolerance to antiretroviral treatment in patients with human immunodeficiency virus infection].. PubMed. 14(9). 445–9. 6 indexed citations
20.
Goodwin, T. Murphy, et al.. (1992). Asphyxial complications in the term newborn with severe umbilical acidemia. American Journal of Obstetrics and Gynecology. 167(6). 1506–1512. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sônia K. Nishida Breakdown of academic impact, for papers by Anders Erik Astrup Dahm Breakdown of academic impact, for papers by Eva Mildenberger Breakdown of academic impact, for papers by Metin İngeç Breakdown of academic impact, for papers by Jacques Lombet Breakdown of academic impact, for papers by Kenneth Chan Breakdown of academic impact, for papers by Jens Drube Breakdown of academic impact, for papers by Hayato Go Breakdown of academic impact, for papers by Noriyoshi Watanabe Breakdown of academic impact, for papers by Naci Kemal Kuşçu
Rankless by CCL
2026